Related Experiment Video
Updated: Feb 4, 2026
07:41
Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
3.4K
[CLINICAL CHARACTERISTICS OF PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH PEPTIC DUODENAL ULCER AFTER ACUTE
Summary
Arterial hypertension (AH) complicates peptic duodenal ulcers (DU), intensifying pain and digestive issues. When AH and DU coexist, hypertensive crises and Helicobacter pylori infections are more frequent, impacting clinical presentation.
Area of Science:
- Gastroenterology
- Cardiology
- Internal Medicine
Background:
- Peptic duodenal ulcer (DU) and arterial hypertension (AH) are common conditions.
- Acute gastrointestinal bleeding (AGB) is a serious complication.
- The interplay between DU, AH, and AGB requires further clinical characterization.
Purpose of the Study:
- To investigate the clinical characteristics of peptic duodenal ulcers (DU) associated with arterial hypertension (AH) following acute gastrointestinal bleeding (AGB).
Main Methods:
- Retrospective analysis of patient data.
- Inclusion of five patient groups: AH with DU, AH in AGB, AGB without AH, AH without AGB, and DU without AH.
- Assessment of clinical symptoms, Helicobacter pylori antibody concentration, and hypertensive crisis occurrence.
Main Results:
- AH co-occurring with existing DU exacerbates pain and dyspeptic symptoms.
- When DU develops in patients with AH, the ulcer's clinical presentation becomes less distinct.
- Elevated Helicobacter pylori antibodies were most prevalent in patients with AH and AGB.
- Hypertensive crises occurred more frequently in the combined AH and DU group.
Conclusions:
- The presence of arterial hypertension significantly influences the clinical manifestation of peptic duodenal ulcers, particularly in the context of acute gastrointestinal bleeding.
- Combined arterial hypertension and duodenal ulcer disease increases the risk of hypertensive crises and is associated with higher Helicobacter pylori antibody levels.
More Related Videos
Related Concept Videos
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
602
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
602
01:28Peptic Ulcer Disease II: Pathophysiology
2.1K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.1K
01:30Peptic Ulcer Disease I: Introduction
844
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
844
01:26Peptic Ulcer Disease IV: Management
504
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
504
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
1.2K
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.2K
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.2K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.2K